Heparan sulfate proteoglycans undergo differential expression alterations in right sided colorectal cancer, depending on their metastatic character

Autor: Fernández-Vega, I.; García-Suárez, O.; García, B.; Crespo Susperregui, Ainara; Astudillo, A.; Quirós, L.M.; 

Tipo de documento: Artículo de revista

Revista: BMC Cancer. ISSN: 1471-2407. Año: 2015. Número: 1. Volumen: 15. Páginas: 1-.

doi 10.1186/s12885-015-1724-9

CIRC: GRUPO A

Referencias:

  • Parkin, D.M., Bray, F., Ferlay, J., Pisani, P., Global cancer statistics, 2002 (2005) CA Cancer J Clin, 55, pp. 74-108
  • Manne, U., Shanmugam, C., Katkoori, V.R., Bumpers, V.R., Grizzle, W.E., Development and progression of colorectal neoplasia (2010) Cancer Biomark, 9, pp. 235-265
  • Richman, S., Adlard, J., Left and right sided large bowel cancer (2002) BMJ, 324, pp. 931-932
  • Chau, B.N., Diaz, R.L., Saunders, M.A., Cheng, C., Chang, A.N., Warrener, P., Bradshaw, J., Claeary, M.A., Identification of SULF2 as a novel transcriptional target of p53 by use of integrated genomic analyses (2009) Cancer Res, 69, pp. 1368-1374
  • Baraz, L., Haupt, Y., Elkin, M., Peretz, T., Vlodaysky, I., Tumor suppressor p53 regulates heparanase gene expression (2006) Oncogene, 25, pp. 3939-3947
  • Truant, S., Bruyneel, E., Gouyer, V., Wever, O., Pruvot, F.R., Mareet, M., Huet, G., Requirement of both mucins and proteoglycans in cell-cell dissociation and invasiveness of colon carcinoma HT-29 cells (2003) Int J Cancer, 104, pp. 683-694
  • Rider, C.C., Heparin/heparan sulphate binding in the TGF-beta cytokine superfamily (2006) Biochem Soc Trans, 34, pp. 458-460
  • Lai, J.P., Oseini, A.M., Moser, C.D., Yu, C., Elsawa, S.F., Hu, C., Nakamura, I., Roberts, L.R., The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation (2010) Hepatology, 52, pp. 1680-1689
  • Sakane, H., Yamamoto, H., Matsumoto, S., Sato, A., Kikuchi, A., Localization of glypican-4 in different membrane microdomains is involved in the regulation of Wnt signaling (2012) J Cell Sci, 125, pp. 449-460
  • Zhao, W., McCallum, S.A., Xiao, Z., Zhang, F., Linhardt, R.J., Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides (2012) Biosci Rep, 32, pp. 71-81
  • Mahtouk, K., Cremer, F.W., Rème, T., Jourdan, M., Baudard, M., Moreaux, J., Requirand, G., Klein, B., Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma (2006) Oncogene, 25, pp. 7180-7191
  • Maglietta, R., Liuzzi, V.C., Cattaneo, E., Laczko, E., Piepoli, A., Panza, A., Carella, M., Ancona, N., Molecular pathways undergoing dramatic transcriptomic changes during tumor development in the human colon (2012) BMC Cancer, 12, p. 608
  • Esko, J.D., Lindahl, U., Molecular diversity of heparan sulphate (2001) J Clin Invest, 108, pp. 169-173
  • Whitelock, J.M., Iozzo, R.V., Heparan sulfate: a complex polymer charged with biological activity (2005) Chem Rev, 105, pp. 2745-2764
  • Park, P.W., Reizes, O., Bernfields, M., Cell surface heparan sulfate proteoglycans: selective regulators of ligand-receptor encounters (2000) J Biol Chem, 275, pp. 29923-29926
  • Sanderson, R.D., Heparan sulfate proteoglycans in invasion and metastasis (2001) Semin Cell Dev Biol, 12, pp. 89-98
  • García-Suárez, O., Fernández-Vega, I., Quirós, L.M., Multiple alterations of heparan sulfate in cancer (2013) OA Cancer, 1, p. 1
  • Park, H., Kim, Y., Lim, Y., Han, I., Oh, E.S., Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells (2002) J Biol Chem, 277, pp. 29730-29736
  • Bouziges, F., Simon-Assmann, P., Leberquier, C., Marescaux, J., Bellocq, J.P., Haffen, K., Kedinger, M., Changes in glycosaminoglycan synthesis and in heparan sulfate deposition in human colorectal adenocarcinomas (1990) Int J Cancer, 46, pp. 189-197
  • Jayson, G.C., Lyon, M., Paraskeva, C., Turnbull, J.E., Deakin, J.A., Gallagher, J.T., Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro (1998) J Biol Chem, 273, pp. 51-57
  • Karibe, T., Fukui, H., Sekikawa, A., Shiratori, K., Fujimori, T., EXTL3 promoter methylation down-regulates EXTL3 and heparan sulphate expression in mucinous colorectal cancers (2008) J Pathol, 216, pp. 32-42
  • Miyamoto, K., Asada, K., Fukutomi, T., Okochi, E., Yagi, Y., Hasegawa, T., Asahara, T., Ushijima, T., Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers (2003) Oncogene, 22, pp. 274-280
  • Schefe, J.H., Lehmann, K.E., Buschmann, I.R., Unger, T., Funke-Kaiser, H., Quantitative real-time RT-PCR data analysis: current concepts and the novel "
  • gene expression's CT difference"
  • formula (2006) J Mol Med, 84, pp. 901-910
  • Sarrazin, S., Lamanna, W.C., Esko, J.D., Heparan sulfate proteoglycans (2011) Cold Spring Harb Perspect Biol, 3, pp. 1-34
  • Kolset, S.O., Tveit, H., Serglycin-structure and biology (2008) Cell Mol Life Sci, 65, pp. 1073-1085
  • Carlsson, P., Kjellén, L., Heparin biosynthesis (2012) Handb Exp Pharmacol, 207, pp. 23-41
  • Kreuger, J., Kjellén, L., Heparan sulfate biosynthesis: regulation and variability (2012) J Histochem Cytochem, 60, pp. 898-907
  • Nairn, A.V., Kinoshita-Toyoda, A., Toyoda, H., Xie, J., Harris, K., Dalton, S., Kulik, M., Linhardt, R.J., Glycomics of Proteoglycan Biosynthesis in Murine Embryonic Stem Cell Differentiation (2007) J Proteome Res, 6, pp. 4374-4387
  • Arvatz, G., Shafat, I., Levy-Adam, F., Ilan, N., Vlodavsky, I., The heparanase system and tumor metastasis: is heparanase the seed and soil? (2011) Cancer Metast Rev, 30, pp. 253-268
  • Raman, K., Kuberan, B., Chemical Tumor Biology of Heparan Sulfate Proteoglycans (2010) Curr Chem Biol, 4, pp. 20-31
  • Theocharis, A., Skandalis, S.S., Tzanakakis, G.N., Karamanos, N.K., Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting (2010) FEBS J, 277, pp. 3904-3923
  • Arvatz, G., Barash, U., Nativ, O., Ilan, N., Vlodaavsky, I., Post-transcriptional regulation of heparanase gene expression by a 3' AU-rich element (2010) FASEB J, 24, pp. 4969-4976
  • Grobe, K., Esko, J.D., Regulated translation of heparan sulfate N-acetylglucosamine N-deacetylase/N-sulfotransferase isozymes by structured 5'-untranslated regions and internal ribosome entry sites (2002) J Biol Chem, 277, pp. 30699-30706
  • Yeaman, C., Rapraeger, A.C., Post-transcriptional regulation of syndecan-1 expression by cAMP in peritoneal macrophages (1993) J Cell Biol, 122, pp. 941-950
  • Day, R.M., Hao, X., Ilyas, M., Changes in the expression of syndecan-1 in the colorectal adenoma-carcinoma sequence (1999) Virchows Arch, 434, pp. 121-125
  • Peretti, T., Waisberg, J., Mader, A.M., Matos, L.L., Costa, R.B., Conceicao, G.M., Lopes, A.C., Pinhal, M.A., Heparanase-2, syndecan-1, and extracellular matrix remodeling in colorectal carcinoma (2008) Eur J Gastroenterol Hepatol, 20, pp. 756-765
  • Hashimoto, Y., Skacel, M., Adams, J.C., Association of loss of epithelial syndecan-1 with stage and local metastasis of colorectal adenocarcinomas: an immunohistochemical study of clinically annotated tumors (2008) BMC Cancer, 8, p. 185
  • Mitselou, A., Skoufi, U., Tsimogiannis, K.E., Briasoulis, E., Vougiouklakis, T., Arvanitis, D., Ioachim, E., Association of syndecan-1 with angiogenesis-related markers, extracellular matrix components, and clinicopathological features in colorectal carcinoma (2012) Anticancer Res, 32, pp. 3977-3985
  • Conejo, J.R., Kleeff, J., Koliopanos, A., Matsuda, K., Zhu, Z.W., Goecke, H., Bincheng, N., Büchler, M.W., Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers (2000) Int J Cancer, 88, pp. 12-20
  • Szatmári, T., Dobra, K., The Role of Syndecan-1 in Cellular Signaling and its Effects on Heparan Sulfate Biosynthesis in Mesenchymal Tumors (2013) Front Oncol, 3, p. 310
  • Filmus, J., Capurro, M., Rast, J., Glypicans (2008) Genome Bio, 9, p. 224
  • Suhovskih, A.V., Mostovich, L.A., Kunin, I.S., Boboev, M.M., Neopmnyashchikh, G.I., Aidagulova, S.V., Grigorieva, E.V., Proteoglycan expression in normal human prostate tissue and prostate cancer (2013) ISRN Oncol, 2013, p. 680136
  • Su, G., Meyer, K., Nandini, C.D., Qiao, D., Salamat, S., Friedl, A., Glypican-1 is frequently overexpressed in human gliomas and enhances FGF-2 signaling in glioma cells (2006) Am J Pathol, 168, pp. 2014-2206
  • Kleeff, J., Ishiwata, T., Kumbasar, A., Friess, H., Büchler, M.W., Korc, M., The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer (1998) J Clin Invest, 102, pp. 1662-1667
  • Matsuda, K., Maruyama, H., Guo, F., Kleeff, J., Itakura, J., Matsumoto, Y., Lander, A.D., Korc, M., Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells (2001) Cancer Res, 61, pp. 5562-5569
  • García-Suárez, O., García, B., Fernández-Vega, I., Astudillo, A., Quirós, L.M., Neuroendocrine tumors show altered expresión of chondroitin sulfate, glypican 1, glypican 5, and syndecan 2 depending on their differentiation grade (2014) Front Oncol, 4, p. 15
  • Fico, A., Maina, F., Dono, R., Fine-tuning of cell signalling by glypicans (2011) Cell Mol Life Sci, 68, pp. 923-929
  • Jia, H.L., Ye, Q.H., Qin, L.X., Budhu, A., Forgues, M., Chen, Y., Liu, Y.K., Wang, X.W., Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma (2007) Clin Cancer Res, 13, pp. 1133-1139
  • Lau, C.S., Yu, C.B., Wong, H.K., Fan, D.S., Wong, K.W., Lam, D.S., Pang, C.F., Choy, K.W., Allelic imbalance at 13q31 is associated with reduced GPC6 in Chinese with sporadic retinoblastoma (2010) Br J Ophthalmol, 94, pp. 357-362
  • Campos-Xavier, A.B., Martinet, D., Bateman, J., Belluoccio, D., Rowley, L., Tan, T.Y., Baxová, A., Bonafé, L., Mutations in the heparan-sulfate proteoglycan glypican 6 (GPC6) impair endochondral ossification and cause recessive omodysplasia (2009) Am J Hum Genet, 84, pp. 760-770
  • Yiu, G.K., Kaunisto, A., Chin, Y.R., Toker, A., NFAT promotes carcinoma invasive migration through glypican-6 (2011) Biochem J, 440, pp. 157-166
  • Cooper, D.L., Dougherty, G.J., To metastasize or not? Selection of CD44 splice sites (1995) Nat Med, 1, pp. 635-637
  • Kuniyasu, H., Oue, N., Tsutsumi, M., Tahara, E., Yasui, W., Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3 (2001) Clin Cancer Res, 7, pp. 4067-4072
  • Hempel, N., How, T., Dong, M., Murphy, S., Fileds, T.A., Blobe, G.C., Loss of betaglycan expression in ovarian cancer: role in motility and invasión (2007) Cancer Res, 67, pp. 5231-5238
  • Bernabeu, C., Lopez-Novoa, J.M., Quintanilla, M., The emerging role of TGF-beta superfamily coreceptors in cancer (2009) Biochim Biophys Acta, 1792, pp. 954-973
  • Criswell, T.L., Dumont, N., Barnett, J.V., Arteaga, C.L., Knockdown of the transforming growth factor-beta type III receptor impairs motility and invasion of metastatic cancer cells (2008) Cancer Res, 68, pp. 7304-7312
  • Woszczyk, D., Gola, J., Jurzak, M., Mazurek, U., Mykata-Ciesla, J., Wilczok, T., Expression of TGF beta1 genes and their receptor types I, II, and III in low- and high-grade malignancy non-Hodgkin's lymphomas (2004) Med Sci Monit, 10, pp. 33-37
  • Jelinek, D.F., Tschumper, R.C., Stolovitzky, G.A., Iturria, S.J., Tu, Y., Lepre, J., Shah, N., Kay, N.E., Identification of a global gene expression signature of B-chronic lymphocytic leucemia (2003) Mol Cancer Res, 1, pp. 346-361
  • Iozzo, R.V., Zoeller, J.J., Nyström, A., Basement membrane proteoglycans: modulators Par Excellence of cancer growth and angiogenesis (2009) Mol Cells, 27, pp. 503-513
  • Xinnong, J., Couchman, J., Perlecan and tumor angiogenesis (2003) J Histochem Cytochem, 51, pp. 1393-1410
  • Nielsen, J.S., McNagny, K.M., Novel functions of the CD34 family (2008) J Cell Sci, 121, pp. 3683-3692
  • Li, Q., Olsen, B.R., Increased angiogenic response in aortic explants of collagen XVIII/endostatin-null mice (2004) Am J Pathol, 165, pp. 415-424
  • Korpetinou, A., Skandalis, S.S., Labropoulou, V.T., Smirlaki, G., Noulas, A., Karamanos, N.K., Theocharis, A.D., Serglycin: At the Crossroad of Inflammation and Malignancy (2014) Front Oncol, 3, p. 327
  • He, L., Zhou, X., Qu, C., Tang, Y., Zhang, Q., Hong, J., Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients (2013) Med Oncol, 30, p. 707
  • Li, X.J., Ong, C.K., Cao, Y., Xiang, Y.Q., Shao, J.Y., Ooi, A., Peng, L.X., Qian, C.N., Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis (2011) Cancer Res, 71, pp. 3162-3172
  • Korpetinou, A., Skandalis, S.S., Moustakas, A., Happonen, K.E., Tveit, H., Prydz, K., Labropoulou, V.T., Theocharis, A.D., Serglycin is implicated in the promotion of aggressive phenotype of breast cancer cells (2013) PLoS One, 8, p. 10
  • Iozzo, R.V., Heparan sulfate proteoglycans: intrincate molecules with intriguing functions (2001) J Clin Invest, 108, pp. 165-167
  • Pönighaus, C., Ambrosius, M., Casanova, J.C., Prante, C., Kuhn, J., Esko, J.D., Kleesiek, K., Götting, C., Human xylosyltransferase II is involved in the biosynthesis of the uniform tetrasaccharide linkage region in chondroitin sulphate and heparan sulphate proteoglycans (2007) J Biol Chem, 282, pp. 5201-5206
  • Venkatesan, N., Barré, L., Magdalou, J., Mainard, D., Netter, P., Fournel-Gigleux, S., Ouzzine, M., Modulation of xylosyltransferase I expression provides a mechanism regulating glycosaminoglycan chain synthesis during cartilage destruction and repair (2009) FASEB J, 23, pp. 813-822
  • Nadanaka, S., Zhou, S., Kagiyama, S., Shoji, N., Sugahara, K., Sugihara, K., Asano, M., Kitagawa, H., EXTL2, a member of EXT family of tumor suppressor, controls glycosaminoglycan biosynthesis in a xylose kinase-dependent manner (2013) J Biol Chem, 288, pp. 9321-9333
  • Mizumoto, S., Ikegawa, S., Sugahara, K., Human genetic disorders caused by mutations in genes encoding biosynthetic enzymes for sulfated glycosaminoglycans (2013) J Biol Chem, 288, pp. 10953-10961
  • Kalathas, D., Theocharis, D.A., Bounias, D., Chondroitin synthases I, II, III and chondroitin sulfate glucuronyltransferase expression in colorectal cancer (2011) Mol Med Rep, 4, pp. 363-368
  • Joo, E.J., Weyers, A., Li, G., Gasimli, L., Li, L., Choi, W.J., Lee, K.B., Linhardt, R.J., Carbohydrate-Containing Molecules as Potential Biomarkers in Colon Cancer (2014) OMICS, 18, pp. 231-241
  • Iozzo, R.V., Bolender, R.P., Wight, T.N., Proteoglycan changes in the intercellular matrix of human colon carcinoma: an integrated biochemical and stereologic analysis (1982) Lab Invest, 47, pp. 124-138
  • Grobe, K., Ledin, J., Ringvall, M., Holmborn, K., Forsberg, E., Esko, J.D., Kjellén, L., Heparan sulfate and development: differential roles of the N-acetylglucosamine N-deacetylase/N-sulfotransferase isozymes (2002) Biochim Biophys Acta, 1573, pp. 209-215
  • Kalathas, D., Theocharis, D.A., Bounias, D., Kyriakopoulou, D., Papageorgakopoulou, N., Stavropoulos, M.S., Vynios, D.H., Alterations of glycosaminoglycan disaccharide content and composition in colorectal cancer: structural and expressional Studies (2009) Oncol Rep, 22, pp. 369-375
  • Smeds, E., Habuchi, H., Do, A.T., Hjertson, E., Grundberg, H., Kimata, K., Lindahl, U., Kusche-Gullberg, M., Substrate specificities of mouse heparan sulphate glucosaminyl 6-O-sulphotransferases (2003) Biochem J, 372, pp. 371-380
  • Thacker, B.E., Xu, D., Lawrence, R., Esko, J.D., Heparan sulfate 3-O-sulfation: A rare modification in search of a function (2014) Matrix Biol, 30, pp. 60-72
  • Tátrai, P., Egedi, K., Somorácz, A., Kuppevelt, T.H., Dam, G., Lyon, M., Deakin, J.A., Kovalszky, I., Quantitative and qualitative alterations of heparan sulphate in fibrogenic liver diseases and hepatocellular cancers (2010) J Histochem Cytochem, 58, pp. 429-441
  • Wade, A., Robinson, A.E., Engler, J.R., Petrisch, C., James, C.D., Phillips, J.J., Proteoglycans and their roles in brain cancer (2013) FEBS J, 280, pp. 2399-2417
  • Bui, C., Ouzzine, M., Talhaoui, I., Sharp, S., Prydz, K., Coughtrie, M.W., Fournel-Gigleux, S., Epigenetics: methylation-associated repression of heparan sulfate 3-O-sulfotransferase gene expression contributes to the invasive phenotype of H-EMC-SS chondrosarcoma cells (2010) FASEB J, 24, pp. 436-450
  • Fernández-Vega, I., García, O., Crespo, A., Castañón, S., Menéndez, P., Astudillo, A., Quirós, L.M., Specific genes involved in synthesis and editing of heparan sulphate proteoglycans show altered expression patterns in breast cancer (2013) BMC Cancer, 13, p. 24
  • Asimakopoulou, A.P., Theocharis, A.D., Tzanakakis, G.N., Karamanos, N.K., The biological role of chondroitin sulfate in cancer and chondroitin-based anticancer agents (2008) In Vivo, 22, pp. 385-389
  • Theocharis, A.D., Theocharis, D.A., High-performance capillary electrophoretic analysis of hyaluronan and galactosaminoglycan-disaccharides in gastrointestinal carcinomas. Differential disaccharide composition as a possible tool-indicator for malignancies (2002) Biomed Chromatogr, 16, pp. 157-161
  • Friedmann, Y., Vlodavsky, I., Aingorn, H., Aviv, A., Peretz, T., Pecker, I., Pappo, O., Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis (2000) Am J Pathol, 157, pp. 1167-1175
  • Nobuhisa, T., Naomoto, Y., Ohkawa, T., Takaoka, M., Ono, R., Murata, T., Gunduz, M., Tanaka, N., Heparanase expression correlates with malignant potential in human colon cancer (2005) J Cancer Res Clin Oncol, 131, pp. 229-237
  • Hermano, E., Lerner, I., Elkin, M., Heparanase enzyme in chronic inflammatory bowel disease and colon cancer (2012) Cell Mol Life Sci, 69, pp. 2501-2513
  • Peerless, Y., Simon, E., Sabo, E., Ben-Izhak, O., Hershkovitz, D., Normal colon tissue and colon carcinoma show no difference in heparanase promoter methylation (2013) Exp Mol Pathol, 94, pp. 309-313
  • Levy-Adam, F., Feld, S., Cohen-Kaplan, V., Shteingauz, A., Gross, M., Arvatz, G., Naroditsky, I., Vlodavsky, I., Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity (2010) J Biol Chem, 285, pp. 28010-28019